Stockscreener 앱 받기
0.6256
2.87%
-0.0185
시간 외 거래:
.63
0.0044
+0.70%
Calidi Biotherapeutics Inc 주식(CLDI)의 최신 뉴스
CLDI Stock Plummets to 52-Week Low at $0.6 Amid Market Turbulence - Investing.com
Calidi Biotherapeutics Bolsters Cash Balance and Terminates Standby Equity Purchase AgreementSAN DIEGO, January 28, 2025 – Calidi Biotherapeutics Inc. (NYSE American: CLDI) recently disclosed the ending cash balance amounting to approximately $ - Defense World
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5 - The Manila Times
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5 - GlobeNewswire
Inside Calidi's Game-Changing Cancer Treatment Pipeline: Top Execs Reveal Next-Gen Therapies - StockTitan
CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Calidi Biotherapeutics Ends SEPA After Successful Fundraising - TipRanks
Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement - GlobeNewswire
Cancer Biotech Raises $18.8M War Chest to Fast-Track Revolutionary Brain Cancer Treatment - StockTitan
Why Calidi Biotherapeutics Inc (AMEX: CLDI) Is A Great Stock Pick For Momentum Investors - Stocks Register
CLDI stock touches 52-week low at $0.73 amid market challenges - MSN
The Business Case For Buying Calidi Biotherapeutics Inc (AMEX: CLDI) Stock Now - Stocks Register
Calidi Biotherapeutics Announces Presentation of New Data - GlobeNewswire
Calidi Biotherapeutics to Present Breakthrough Cancer Treatment Platform at AACR 2025 Meeting - StockTitan
Calidi Biotherapeutics announces reverse stock split adjustment - Investing.com
Calidi Biotherapeutics Inc (CLDI-A) QuotePress Release - The Globe and Mail
Calidi Biotherapeutics Announces $4.25 Million Public Stock Offering - Defense World
Calidi Biotherapeutics Refiles Consolidated Financial Statements After Reverse Stock Split - Defense World
Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock - The Bakersfield Californian
Calidi Biotherapeutics Raises $4.25M Through Public Offering of Common Stock at $0.85 Per Share - StockTitan
Why Calidi Biotherapeutics (CLDI) Stock Is Down 30% - Benzinga
Calidi Biotherapeutics slumps 29%, prices $4.25M stock offering - MSN
Calidi Biotherapeutics Announces Public Stock Offering Deal - TipRanks
Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock - The Bakersfield Californian
Calidi Biotherapeutics Raises $4.25M Through Public Offering to Advance Cancer Immunotherapy Platform - StockTitan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Calidi Biotherapeutics (NYSE:CLDI) Stock Price Down 8.2% – Should You Sell? - Defense World
Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times
Calidi Biotherapeutics Announces Common Stock Public Offering to Advance Immunotherapy Pipeline - StockTitan
Reviewing Calidi Biotherapeutics (NYSE:CLDI) & iTeos Therapeutics (NASDAQ:ITOS) - Defense World
Comparing Calidi Biotherapeutics (NYSE:CLDI) & Immatics (NASDAQ:IMTX) - Defense World
Calidi Biotherapeutics CEO Allan Camaisa sells $16,200 in stock - Investing.com India
Calidi Biotherapeutics prices $7.5M secondary offering - MSN
Calidi Biotherapeutics (NYSE American: CLDI) Data Demonstrates Potential of Innovative Solutions to Revolutionize Cancer Care - Barchart
UMACUnusual Machines, Inc. Latest Stock News & Market Updates - StockTitan
Calidi Biotherapeutics (NYSE American: CLDI) Shares Data Supporting Proprietary Systemic Antitumor Platform - Barchart
Calidi Biotherapeutics announces pricing of $7.5M public offering of common stock - MSN
Calidi Biotherapeutics (NYSE American: CLDI) Raises $7.5 Million Through Public Stock Offering - Barchart
If You Don’t Buy Calidi Biotherapeutics Inc (AMEX: CLDI) Now, You’ll Kick Yourself Later - Stocks Register
Calidi Biotherapeutics Reveals Promising Virotherapy Data - TipRanks
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer - EIN News
Calidi presents data on RTNova systemic technology in metastatic lung cancer - TipRanks
Calidi Bio's RTNova Shows Promise in Metastatic Lung Cancer Treatment Breakthrough | CLDI Stock News - StockTitan
Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock - The Manila Times
Calidi Biotherapeutics Raises $7.5M Through Public Offering of 4.4M Shares | CLDI Stock News - StockTitan
Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews
SEC Form 424B5 filed by Calidi Biotherapeutics Inc. - Quantisnow
Calidi prices 4.4M shares at $1.69 in public offering - TipRanks
5.49%
0.79%
자본화:
|
볼륨(24시간):